Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 32, 2022 - Issue 8
Submit an article Journal homepage
356
Views
12
CrossRef citations to date
0
Altmetric
Review

Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022

Sridhar Goud Nerellaa Department of Neuroimaging and Interventional Radiology (NI & IR), National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India;b Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, IndiaORCID Iconhttps://orcid.org/0000-0002-0132-9516View further author information
ORCID Icon,
Priti Singhb Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, IndiaView further author information
,
Mohammed Arifuddinb Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India;c Department of Chemistry, Directorate of Distance Education, Maulana Azad National Urdu University, Gachibowli, Hyderabad, T.S.IndiaCorrespondence[email protected]
View further author information
&
Claudiu T Supurand Neurofarba Department, Università degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sesto Fiorentino, Florence, ItalyCorrespondence[email protected]
View further author information
Pages 833-847 | Received 16 Mar 2022, Accepted 25 May 2022, Published online: 02 Jun 2022

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Morteza Abdoli, Alessandro Bonardi, Claudiu T. Supuran & Raivis Žalubovskis. (2023) 4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 156-165.
Read now
Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 0:0, pages 1-20.
Read now
Tarfah Al-Warhi, Mostafa M. Elbadawi, Alessandro Bonardi, Alessio Nocentini, Ahmed A. Al-Karmalawy, Nada Aljaeed, Ohoud J. Alotaibi, Hatem A. Abdel-Aziz, Claudiu T. Supuran & Wagdy M. Eldehna. (2022) Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2635-2643.
Read now
Mahmoud F. Abo-Ashour, Hadia Almahli, Alessandro Bonardi, Amira Khalil, Tarfah Al-Warhi, Sara T. Al-Rashood, Hatem A. Abdel-Aziz, Alessio Nocentini, Claudiu T. Supuran & Wagdy M. Eldehna. (2022) Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2256-2264.
Read now

Articles from other publishers (8)

Monalisa Mahapatra, Suman K. Mekap, Suvadeep Mal, Jyotirmaya Sahoo, Sanjeeb K. Sahoo & Sudhir K. Paidesetty. (2023) Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward  h CA IX/XII, facilitating anticancer drug development . Archiv der Pharmazie 356:4.
Crossref
Toni C. Denner, Niels Heise, Julian Zacharias, Oliver Kraft, Sophie Hoenke & René Csuk. (2023) Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates. Molecules 28:3, pages 1009.
Crossref
Claudiu T Supuran. (2023) Latest advances in specific inhibition of tumor-associated carbonic anhydrases. Future Medicinal Chemistry 15:1, pages 5-7.
Crossref
Samira Zareei, Maryam Mohammadi-Khanaposhtani, Mehdi Adib, Mohammad Mahdavi & Parham Taslimi. (2023) Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: In vitro enzymatic inhibition, molecular modeling, and ADMET prediction. Journal of Molecular Structure 1271, pages 134114.
Crossref
Heba T. Abdel‐Mohsen, Mohamed A. Omar, Andrea Petreni & Claudiu T. Supuran. (2022) Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. Archiv der Pharmazie 355:12.
Crossref
Divya Rai, Satyajit Khatua & Srabani Taraphder. (2022) Structure and Dynamics of the Isozymes II and IX of Human Carbonic Anhydrase. ACS Omega 7:35, pages 31149-31166.
Crossref
Simone Giovannuzzi, Clemente Capasso, Alessio Nocentini & Claudiu T. Supuran. (2022) Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII. Molecules 27:13, pages 4076.
Crossref
Benjamin Brandes, Torje E. Orlamünde, Sophie Hoenke, Toni C. Denner, Ahmed Al-Harrasi & René Csuk. (2022) Selective and low-cost triterpene urea and amide derivatives of high cytotoxicity and selectivity. Results in Chemistry 4, pages 100610.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.